Peak Resources- Shelby: Pharmacy Service Gaps - NC
The resident at the center of this, identified in inspection records only as Resident #75, is a diabetic woman whose physician assistant ordered semaglutide on November 25, 2025, to help regulate her blood sugars and assist with weight loss. Semaglutide, sold under brand names including Ozempic and Wegovy, is administered by injection once a week. Her orders called for it every Monday.
It never came on the first Monday. Or the second. Or the third.
What came instead were documentation entries suggesting otherwise. The Medication Administration Record showed that Nurse #2 gave Resident #75 the injection on December 1 at 8:00 AM. It showed the resident refused it on December 8. It showed the December 15 dose was held because the pharmacy hadn't delivered it yet.
When inspectors interviewed Nurse #2 on February 9, 2026, she acknowledged that none of those entries reflected what actually happened. The medication was unavailable on all three dates, December 1, December 8, and December 15. She said she documented the December 1 dose as administered in error, and that the December 8 refusal notation was also wrong. She should have written, each time, that the medication was simply not on hand.
Resident #75 told inspectors the same thing. Cognitively intact, according to her assessment, she spoke with clarity about what had happened. The physician assistant ordered the medication in November. She did not receive it until January 2026.
The pharmacist, reached by phone on the day inspectors completed their visit, filled in the gap on the supply side. The facility sent an order for semaglutide on November 25, but the order did not include dosage information. The pharmacy could not fill it. The facility eventually sent a corrected order specifying 0.25 mg, and the medication was delivered sometime after that, though the exact delivery date was redacted in the inspection record.
What the pharmacist's account makes clear is that the documentation problem ran in both directions. The facility sent an incomplete order and did not catch it. The nurse recorded administrations that never occurred and did not correct them. And the gap between what the MAR said and what the resident actually received persisted across at least six weeks without anyone flagging it internally.
The administrator, interviewed on the afternoon of February 11, said she had no idea Resident #75 had gone without the medication. She said that when a dose is missed, the record should reflect the actual reason accurately.
Inspectors made several attempts to reach the former Director of Nursing. None were successful.
The inspection was conducted on February 11, 2026, and the violation was cited at a level of minimal harm or potential for actual harm, the lower end of CMS's harm scale. The deficiency covered one resident reviewed for accurate medication records, and one resident was found to have records that did not reflect reality.
Resident #75 spent the weeks her physician assistant intended for her to be on a blood sugar management medication without it, while a document in her file said she had received it, then declined it, then was waiting on it. She waited through December. She got the medication in January. Nobody at the facility, by the administrator's own account, knew the difference until federal inspectors asked.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Peak Resources- Shelby from 2026-02-11 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 4, 2026 · Our methodology
Peak Resources- Shelby in Grover, NC was cited for violations during a health inspection on February 11, 2026.
Semaglutide, sold under brand names including Ozempic and Wegovy, is administered by injection once a week.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.